Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kanta Subbarao

Showing results (171-180 of 300) with videos related to

Pageof 30
Sort By:
Plos Medicine|September 14, 2006
Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferretsAmorsolo L Suguitan, Josephine McAuliffe, Kimberly L Mills, et al.
Emerging Infectious Diseases|January 24, 2023
Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 InfectionDavid S Khoury, Timothy E Schlub, Deborah Cromer, et al.
Influenza and Other Respiratory Viruses|December 1, 2022
Antibody titres elicited by the 2018 seasonal inactivated influenza vaccine decline by 3 months post-vaccination but persist for at least 6 monthsFrancesca L Mordant, Olivia H Price, Rajeev Rudraraju, et al.
The Journal of Infectious Diseases|February 13, 2009
A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adultsRuth A Karron, Karen Callahan, Catherine Luke, et al.
Communicable Diseases Intelligence (2018)|February 16, 2022
The 2018 annual cost burden for children under five years of age hospitalised with respiratory syncytial virus in AustraliaNatasha K Brusco, Annette Alafaci, Jane Tuckerman, et al.
Plos Pathogens|August 18, 2017
Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibodyKatherine V Houser, Andrew J Broadbent, Lisa Gretebeck, et al.
Plos Pathogens|April 14, 2010
SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanismMatthew B Frieman, Jun Chen, Thomas E Morrison, et al.
Journal of Virology|May 9, 2008
A live attenuated severe acute respiratory syndrome coronavirus is immunogenic and efficacious in golden Syrian hamstersElaine W Lamirande, Marta L DeDiego, Anjeanette Roberts, et al.
Journal of Virology|December 1, 2017
Pathogenesis, Humoral Immune Responses, and Transmission between Cohoused Animals in a Ferret Model of Human Respiratory Syncytial Virus InfectionKok Fei Chan, Louise A Carolan, Julian Druce, et al.
Nature Medicine|May 18, 2021
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infectionDavid S Khoury, Deborah Cromer, Arnold Reynaldi, et al.
Pageof 30

Showing results (171-180 of 300) with videos related to

Sort By:
Pageof 30
Plos Medicine|September 14, 2006
Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferretsAmorsolo L Suguitan, Josephine McAuliffe, Kimberly L Mills, et al.
Emerging Infectious Diseases|January 24, 2023
Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 InfectionDavid S Khoury, Timothy E Schlub, Deborah Cromer, et al.
Influenza and Other Respiratory Viruses|December 1, 2022
Antibody titres elicited by the 2018 seasonal inactivated influenza vaccine decline by 3 months post-vaccination but persist for at least 6 monthsFrancesca L Mordant, Olivia H Price, Rajeev Rudraraju, et al.
The Journal of Infectious Diseases|February 13, 2009
A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adultsRuth A Karron, Karen Callahan, Catherine Luke, et al.
Communicable Diseases Intelligence (2018)|February 16, 2022
The 2018 annual cost burden for children under five years of age hospitalised with respiratory syncytial virus in AustraliaNatasha K Brusco, Annette Alafaci, Jane Tuckerman, et al.
Plos Pathogens|August 18, 2017
Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibodyKatherine V Houser, Andrew J Broadbent, Lisa Gretebeck, et al.
Plos Pathogens|April 14, 2010
SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanismMatthew B Frieman, Jun Chen, Thomas E Morrison, et al.
Journal of Virology|May 9, 2008
A live attenuated severe acute respiratory syndrome coronavirus is immunogenic and efficacious in golden Syrian hamstersElaine W Lamirande, Marta L DeDiego, Anjeanette Roberts, et al.
Journal of Virology|December 1, 2017
Pathogenesis, Humoral Immune Responses, and Transmission between Cohoused Animals in a Ferret Model of Human Respiratory Syncytial Virus InfectionKok Fei Chan, Louise A Carolan, Julian Druce, et al.
Nature Medicine|May 18, 2021
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infectionDavid S Khoury, Deborah Cromer, Arnold Reynaldi, et al.
Pageof 30